Amgen reported strong quarterly performance with record revenues and earnings, alongside raised full-year guidance reflecting confidence in continued growth. Positive pipeline developments and successful integration efforts regarding the Horizon acquisition further bolster investor sentiment. These factors are likely to drive a positive short-term impact on Amgen's stock.

[1]